Cadila pharma launches biosimilar Rituximab drug Ritucad™ which is used for treatment of blood cancer and rheumatoid arthritis. Ahmedabad-based Cadila Pharmaceuticals recently announced the launch of biosimilar Rituximab for India
Read More
Click Here
